Photo Galleries
Hired and retired: New appointments in the biopharma industry
Biogen, Sartorius and Recipharm are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
J&J, Vir Biotechnology and Ocugen are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
Catalent, SK bioscience and CureVac are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
Moderna, Novavax and Biogen are among the companies welcoming new faces to top jobs this month.
Hired and retired: New appointments in the biopharmaceutical industry
New year, new job: We take a look at some of the experts taking on top roles in the biopharmaceutical industry this month.
Most popular social media stories of 2022
As the year draws to a close, we look at the stories that got readers sharing on social media platforms.
Hired and retired: New appointments in the biopharma industry
We track career moves in the industry over the past few weeks.
Hired and retired: New appointments in the biopharma industry
Moderna, Rentschler Biopharma and ViroCell Biologics are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
Biogen has named its new CEO: while other companies in the biopharma industry are also welcoming new faces to top jobs.
Most popular stories in October 2022
Novo Nordisk, Sanofi, AstraZenec, Merck and Moderna, among others, feature in our round-up of top hitting stories last month.
Hired and retired: New appointments in the biopharma industry
Novavax, Sk bioscience and Aspen Neuroscience are among the companies welcoming new faces to top jobs.
NPD Gallery: Technology Insider October 2022
We look at the developments in biopharma targeted tech innovation over the past few months.
Hired and retired: New appointments in the biopharma industry
BIO has announced a change in leadership; while GSK and Moderna are also welcoming new faces to top roles.
Hired and retired: New appointments in the biopharma industry
Ginko Bioworks, Inizio and Neuway Pharma are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
Novartis, Rentschler Biopharma and BioAgilytix are among the companies welcoming new faces to top roles.
Hired and retired: New appointments in the biopharma industry
Moderna, Curia and Abzena are among the companies welcoming new faces to top jobs.
Hired and retired: New appointments in the biopharma industry
Pfizer, Valneva and CureVac are all welcoming new faces to top jobs.
NPD Gallery: Technology Insider
We track developments and launches in process engineering tools and research components over the past few weeks.
Hired and retired: New appointments in the biopharma industry
Pfizer, Merck and Moderna are among the companies making changes in top-level jobs this month.
Hired and retired: New year, new job
We take a look at some of the people starting 2022 with a new role in the biopharma industry.
NPD Gallery: Technology insider
What's new in biopharmaceutical manufacturing components and technology? We take a look.
NPD Gallery: Technology Insider
We track some of the more recent developments in biopharma manufacturing tech.
Hired and retired: New appointments in the biopharma industry
Lilly, Sanofi and Catamaran Bio are among the companies making new appointments this month.
NPD Gallery: Technology Insider
We report on some of the latest biopharma industry targeted new releases in terms of technological innovation.
Hired and retired: New appointments in the industry
We take a look at some of the people taking on top jobs in the biopharmaceutical industry this month.
NPD Gallery: Technology Insider
What's new in the world of biopharmaceutical tech this month? We track developments in process innovation equipment.
Hired and retired: New appointments in the biopharma industry
We take a look at some of the people taking on top jobs in the biopharma industry this month.
NPD Gallery: Technology insider
What's new in the world of biopharma tech? We track the latest in process innovation equipment releases.
Hired and retired: Appointments at the top
Lonza, Gilead Sciences and Novavax are among the companies welcoming new faces to top jobs this month.
From biosimilars to process intensification: 5 key trends in the biopharma space today
Efficiency in the biopharmaceutical space has never been more top-of-mind. The COVID-19 pandemic brought an unprecedented urgency to R&D and the key players delivered: Several groups produced a vaccine in record time. To maintain and improve on this...
Hired and retired: Transitions at the top
We take a look at some of the people taking on top jobs in the biopharmaceutical industry this month.
Hired and Retired: Gearing up for 2021
2020 has been an eventful year: but 2021 will also require skilful navigation. Here's some of the people who are stepping up to leading roles as we head into a new year.
Top five stories from October
COVID-19 is like a big oak tree casting shade on all other biopharma industry developments. Vaccine-related articles dominate the most popular story rankings. With Pfizer and BioNTech now out in front in the coronavirus vaccine race, we track the related...
Hired and retired: Appointments at the top
While all eyes are on a certain top job in the US at the moment, the biopharmaceutical industry is also looking at its leaders.
Hired and Retired: This month's appointments
Sanofi, Vibalogics and Evelo Biosciences are among the companies welcoming new faces to top jobs.
Hired & Retired: Taking care of business
The industry plumps for business acumen, as companies seek to turn drug candidates from pipeline prospects to approved products.
Hired & Retired: From big pharma to mid-sized leadership
This month featured executives making the switch from big pharma to take on leadership positions at mid-sized companies.
Hired and Retired: Biotechs buildout at board level
Numerous biotechs have brought onboard further experience at leadership level, with several seeking guidance on lead candidates.
Hired & Retired: Changes amid COVID-19
As the industry shifts gears to combat the novel coronavirus, a number of leadership changes have taken place.
Hired and Retired: Management moves in a time of crisis
As the pandemic continues to rumble on, biopharma companies have been reshuffling the pack on their executive boards.
Hired and Retired: Appointments at the cutting edge
This month there have been a number of changes in the leadership of organizations working on biosimilars and in the advanced therapeutic space.
Hired and Retired: Jumping on gene therapy
The gene therapy space is a rapidly developing areas in the industry, as a result those with expertise are finding their knowledge is invaluable to companies looking to advance in the space.
Hired and Retired: Regulatory turbulence shakes the space
The end of the summer sees several leading companies, including Regeneron, Novartis, and Bayer, experience changes in their leadership.
Hired and Retired: A summer of change
As we have entered the summer, companies have taken to refreshing their leadership positions, including at companies such as Gilead, Alnylam, and Maze Therapeutics.
Hired and Retired: The knock-on effect
BMS’ capture of Celgene caught much attention, due to the size and scale of the acqusition, but rival companies have taken the chance to snap up employees that have left after the deal.
Hired and Retired: Investing in experience
Biotechs continue to pull experienced individuals from larger pharma companies to help progress candidates through the clinic.
Hired and Retired: Spring cleaning
As we enter spring, several companies have refreshed the look of their executive boards – some to strengthen their direction and some out of necessity.
Hired and Retired: Pharma C-suites see new faces
While last month saw many pharma executives leaving their positions to head towards smaller biotech companies, this month saw members of the industry climbing the ladder from various different starting points.
Hired and Retired: High profile exits to biotech
The numbers of high profile executives departing large pharma companies this month again emphasised the draw of working in the biotech industry.